Posted
Video length: 1 min.
Article written by
One tablet could halve the risk of death from a certain type of lung cancer. A hope to increase the chances of survival of the sick. The details of Damien Mascret, present on the set of 20 Hours, Monday June 5.
One tablet represents the new hope of halving the risk of death from lung cancer. “Thanks to this targeted therapy, 5-year mortality drops from 22% to 12%“, details the doctor and journalist Damien Mascret, present on the set of 20 Hours, Monday June 5. “For these lung cancers detected before they have given metastases, this means that we go from eight out of ten patients still alive five years after diagnosis, to nine out of ten patients still alive.he continues.
1,000 patients could benefit from the treatment each year
Unfortunately, not all patients with lung cancer are affected. “For this treatment in particular, so-called ‘non-small cell’ cancers are targeted, which represent 90% of lung cancers, but they must also have a particular mutation, called EGRF, which is the case in 10 to 15 % of cases”, explains the doctor. “In total, about 1,000 patients could benefit from the treatment each year in France,” he concludes.
Among Our sources:
NEJM
Non-exhaustive list.